| # | Title | Journal | Year | Citations |
|---|
| 1 | Phospholipase A2 enzymes | Prostaglandins and Other Lipid Mediators | 2002 | 632 |
| 2 | The cannabinoid receptors | Prostaglandins and Other Lipid Mediators | 2002 | 406 |
| 3 | Distinct functions of COX-1 and COX-2 | Prostaglandins and Other Lipid Mediators | 2002 | 351 |
| 4 | Cyclooxygenase isozymes and their gene structures and expression | Prostaglandins and Other Lipid Mediators | 2002 | 345 |
| 5 | Lysophosphatidic acid (LPA) receptors: Signaling properties and disease relevance | Prostaglandins and Other Lipid Mediators | 2010 | 308 |
| 6 | Regulation of inflammation in cancer by eicosanoids | Prostaglandins and Other Lipid Mediators | 2011 | 280 |
| 7 | Prostaglandin catabolizing enzymes | Prostaglandins and Other Lipid Mediators | 2002 | 266 |
| 8 | Resolvins, docosatrienes, and neuroprotectins, novel omega-3-derived mediators, and their aspirin-triggered endogenous epimers: an overview of their protective roles in catabasis | Prostaglandins and Other Lipid Mediators | 2004 | 260 |
| 9 | Prostaglandin E synthase | Prostaglandins and Other Lipid Mediators | 2002 | 219 |
| 10 | Omega-3 fatty acids and their lipid mediators: Towards an understanding of resolvin and protectin formation | Prostaglandins and Other Lipid Mediators | 2012 | 218 |
| 11 | Biochemistry and pharmacology of the endocannabinoids arachidonylethanolamide and 2-arachidonylglycerol | Prostaglandins and Other Lipid Mediators | 2000 | 215 |
| 12 | Receptors for acylethanolamides—GPR55 and GPR119 | Prostaglandins and Other Lipid Mediators | 2009 | 204 |
| 13 | Soluble epoxide hydrolase inhibition reveals novel biological functions of epoxyeicosatrienoic acids (EETs) | Prostaglandins and Other Lipid Mediators | 2007 | 185 |
| 14 | Production of EPA and DHA in aquatic ecosystems and their transfer to the land | Prostaglandins and Other Lipid Mediators | 2013 | 183 |
| 15 | Mammalian arachidonate 15-lipoxygenases | Prostaglandins and Other Lipid Mediators | 2002 | 176 |
| 16 | Lipid signaling: Sleep, synaptic plasticity, and neuroprotection | Prostaglandins and Other Lipid Mediators | 2005 | 174 |
| 17 | Sphingosine 1-phosphate: synthesis and release | Prostaglandins and Other Lipid Mediators | 2001 | 172 |
| 18 | Emerging roles of PGE2 receptors in models of neurological disease | Prostaglandins and Other Lipid Mediators | 2010 | 172 |
| 19 | Free fatty acid receptors act as nutrient sensors to regulate energy homeostasis | Prostaglandins and Other Lipid Mediators | 2009 | 171 |
| 20 | Lysophosphatidic acid synthesis and release | Prostaglandins and Other Lipid Mediators | 2001 | 169 |
| 21 | Lipocalin-type and hematopoietic prostaglandin D synthases as a novel example of functional convergence | Prostaglandins and Other Lipid Mediators | 2002 | 169 |
| 22 | Lipoxins and aspirin-triggered 15-epi-lipoxin biosynthesis: an update and role in anti-inflammation and pro-resolution | Prostaglandins and Other Lipid Mediators | 2002 | 169 |
| 23 | Pharmacodynamic of cyclooxygenase inhibitors in humans | Prostaglandins and Other Lipid Mediators | 2007 | 165 |
| 24 | Lipoxygenase genes and their targeted disruption | Prostaglandins and Other Lipid Mediators | 2002 | 162 |
| 25 | Prostaglandin transport | Prostaglandins and Other Lipid Mediators | 2002 | 161 |
| 26 | Omega-3 fatty acids and adipose tissue function in obesity and metabolic syndrome | Prostaglandins and Other Lipid Mediators | 2015 | 159 |
| 27 | Emerging lysophospholipid mediators, lysophosphatidylserine, lysophosphatidylthreonine, lysophosphatidylethanolamine and lysophosphatidylglycerol | Prostaglandins and Other Lipid Mediators | 2009 | 155 |
| 28 | Function of prostanoid receptors: studies on knockout mice | Prostaglandins and Other Lipid Mediators | 2002 | 151 |
| 29 | Sphingosine kinase: a mediator of vital cellular functions | Prostaglandins and Other Lipid Mediators | 2001 | 149 |
| 30 | Biology of endocannabinoid synthesis system | Prostaglandins and Other Lipid Mediators | 2009 | 147 |
| 31 | Signaling, physiological functions and clinical relevance of the G protein-coupled estrogen receptor GPER | Prostaglandins and Other Lipid Mediators | 2009 | 146 |
| 32 | Prostaglandins and other lipid mediators in Alzheimer’s disease | Prostaglandins and Other Lipid Mediators | 2002 | 145 |
| 33 | Prostanoid receptor subtypes | Prostaglandins and Other Lipid Mediators | 2002 | 145 |
| 34 | The enzymology of prostaglandin endoperoxide H synthases-1 and -2 | Prostaglandins and Other Lipid Mediators | 2002 | 143 |
| 35 | Oxidative metabolism of anandamide | Prostaglandins and Other Lipid Mediators | 2000 | 133 |
| 36 | Cytokines, PGE2 and endotoxic fever: a re-assessment | Prostaglandins and Other Lipid Mediators | 2005 | 133 |
| 37 | Endogenous cannabinoids revisited: A biochemistry perspective | Prostaglandins and Other Lipid Mediators | 2013 | 124 |
| 38 | Sphingosine 1-phosphate receptors | Prostaglandins and Other Lipid Mediators | 2001 | 123 |
| 39 | Role of epoxyeicosatrienoic acids in protecting the myocardium following ischemia/reperfusion injury | Prostaglandins and Other Lipid Mediators | 2007 | 122 |
| 40 | The structures of prostaglandin endoperoxide H synthases-1 and -2 | Prostaglandins and Other Lipid Mediators | 2002 | 121 |
| 41 | Platelet-activating factor receptor | Prostaglandins and Other Lipid Mediators | 2002 | 120 |
| 42 | Epoxyeicosatrienoic acids, cell signaling and angiogenesis | Prostaglandins and Other Lipid Mediators | 2007 | 120 |
| 43 | Topical application of a selective cyclooxygenase inhibitor suppresses UVB mediated cutaneous inflammation | Prostaglandins and Other Lipid Mediators | 2000 | 119 |
| 44 | Phospholipase A2 receptor: a regulator of biological functions of secretory phospholipase A2 | Prostaglandins and Other Lipid Mediators | 2002 | 119 |
| 45 | G2A and LPC: Regulatory functions in immunity | Prostaglandins and Other Lipid Mediators | 2009 | 119 |
| 46 | Epoxyeicosanoid signaling in CNS function and disease | Prostaglandins and Other Lipid Mediators | 2010 | 116 |
| 47 | Secretory phospholipase A2 of group IIA: Is it an offensive or a defensive player during atherosclerosis and other inflammatory diseases? | Prostaglandins and Other Lipid Mediators | 2006 | 114 |
| 48 | ω-3 Polyunsaturated fatty acids-derived lipid metabolites on angiogenesis, inflammation and cancer | Prostaglandins and Other Lipid Mediators | 2014 | 112 |
| 49 | The LPA receptors | Prostaglandins and Other Lipid Mediators | 2001 | 111 |
| 50 | Arachidonate 12-lipoxygenases | Prostaglandins and Other Lipid Mediators | 2002 | 111 |
